GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
S

Sinphar Pharmaceutical Co 1734.TW · TWD

Health Care · Taiwan Stock Exchange · 🇹🇼 Taiwan

Compare

30.15

+0.84%

Close of 9 Nov 2026, in TWD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Popular Bitcoin Ethereum Nvidia Apple S&P 500 Gold EUR/USD US 10Y

At a glance

Figures in TWD, from our data supplier.

FY2025

Revenue

TWD 3.37bn

FY2016FY2025

Net income

TWD 365.8m

FY2016FY2025

Free cash flow

TWD 383.7m

FY2016FY2025

Shareholders' equity

TWD 3.44bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueTWD 3.37bnTWD 3.15bnTWD 2.96bnTWD 2.86bnTWD 2.43bnTWD 2.39bnTWD 2.39bnTWD 2.22bnTWD 2.13bnTWD 2.13bn
Gross profitTWD 1.46bnTWD 1.24bnTWD 1.09bnTWD 1.09bnTWD 888.7mTWD 875.5mTWD 940.8mTWD 825.4mTWD 810.3mTWD 789.9m
Research and developmentTWD 145.4mTWD 151.4mTWD 132.6mTWD 272.2mTWD 511.9mTWD 462.4mTWD 527.8mTWD 376.4mTWD 363.5mTWD 382.6m
Operating incomeTWD 416.9mTWD 313.8mTWD 307.5mTWD 219.8m−TWD 163.4m−TWD 122.2m−TWD 63.6m−TWD 67.2m−TWD 63.0m−TWD 13.1m
Net incomeTWD 365.8mTWD 304.7mTWD 375.2mTWD 224.6m−TWD 38.1m−TWD 28.5mTWD 14.0mTWD 8.8mTWD 36.7mTWD 16.5m
Diluted earnings per share1.971.662.061.34-0.21-0.160.080.050.200.09

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsTWD 6.15bnTWD 6.30bnTWD 6.25bnTWD 6.19bnTWD 6.22bnTWD 6.13bnTWD 5.92bnTWD 5.88bnTWD 6.04bnTWD 6.21bn
Cash and short-term investmentsTWD 994.6mTWD 1.18bnTWD 1.08bnTWD 1.24bnTWD 1.24bnTWD 1.19bnTWD 886.1mTWD 975.1mTWD 1.16bnTWD 1.14bn
Total liabilitiesTWD 2.44bnTWD 2.75bnTWD 2.85bnTWD 2.97bnTWD 3.14bnTWD 2.98bnTWD 2.71bnTWD 2.46bnTWD 2.42bnTWD 2.42bn
DebtTWD 1.51bnTWD 1.90bnTWD 1.94bnTWD 1.91bnTWD 2.13bnTWD 2.15bnTWD 1.94bnTWD 1.72bnTWD 1.66bnTWD 1.60bn
Shareholders' equityTWD 3.44bnTWD 3.26bnTWD 3.10bnTWD 2.93bnTWD 2.72bnTWD 2.74bnTWD 2.78bnTWD 2.93bnTWD 3.07bnTWD 3.09bn
Shares outstanding186m183m182m168m181m181m182m181m182m181m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operationsTWD 584.7mTWD 593.5mTWD 296.4mTWD 425.3mTWD 135.5mTWD 146.4m−TWD 79.5mTWD 79.5mTWD 219.9mTWD 87.2m
Capital spending−TWD 200.9m−TWD 256.7m−TWD 300.9m−TWD 153.4m−TWD 161.4m−TWD 157.8m−TWD 176.7m−TWD 255.7m−TWD 171.0m−TWD 224.8m
Free cash flowTWD 383.7mTWD 336.8m−TWD 4.6mTWD 271.9m−TWD 25.9m−TWD 11.4m−TWD 256.2m−TWD 176.2mTWD 48.9m−TWD 137.7m
Dividends paid−TWD 181.1m−TWD 167.7m−TWD 167.7m−TWD 33.5m−TWD 33.5m−TWD 33.5m−TWD 16.8m−TWD 33.5m−TWD 16.8m−TWD 32.3m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueTWD 871.2mTWD 826.6mTWD 880.0mTWD 872.7mTWD 813.0mTWD 805.6mTWD 854.4mTWD 749.5m
Gross profitTWD 408.3mTWD 362.4mTWD 382.5mTWD 364.6mTWD 346.5mTWD 345.5mTWD 347.7mTWD 272.1m
Operating incomeTWD 111.7mTWD 91.3mTWD 96.0mTWD 108.9mTWD 89.3mTWD 111.3mTWD 86.9mTWD 54.7m
Net incomeTWD 92.6mTWD 73.8mTWD 102.0mTWD 83.4mTWD 68.1mTWD 112.4mTWD 81.8mTWD 47.6m
Diluted earnings per share0.490.390.550.450.370.610.450.26
Cash from operationsTWD 78.0mTWD 116.0mTWD 200.0mTWD 203.0mTWD 116.0mTWD 63.0mTWD 188.0mTWD 199.0m
Capital spending−TWD 46.0m−TWD 101.0m−TWD 67.0m−TWD 56.0m−TWD 46.0m−TWD 30.0m−TWD 48.0m−TWD 47.0m
Free cash flowTWD 32.0mTWD 15.0mTWD 133.0mTWD 147.0mTWD 70.0mTWD 33.0mTWD 140.0mTWD 152.0m
Total assetsTWD 6.84bnTWD 6.42bnTWD 6.15bnTWD 6.13bnTWD 6.11bnTWD 6.32bnTWD 6.30bnTWD 6.26bn
Cash and short-term investmentsTWD 1.60bnTWD 1.21bnTWD 994.6mTWD 1.00bnTWD 1.02bnTWD 1.12bnTWD 1.18bnTWD 1.16bn
DebtTWD 629.5mTWD 1.70bnTWD 1.51bnTWD 1.67bnTWD 1.67bnTWD 1.81bnTWD 1.90bnTWD 1.82bn
Shareholders' equityTWD 3.45bnTWD 3.54bnTWD 3.44bnTWD 3.31bnTWD 3.20bnTWD 3.39bnTWD 3.26bnTWD 3.18bn

Financial ratios

Data as of 13 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Gross margin43.2%39.3%36.8%38.2%36.5%36.7%
Operating margin12.9%10.9%11.5%9.6%-6.6%-3.9%
Net margin10.8%9.7%12.7%7.9%-1.6%-1.2%
Return on equity10.6%9.3%12.1%7.7%-1.4%-1.0%
Return on assets5.9%4.8%6.0%3.6%-0.6%-0.5%
Free cash flow yield13.4%14.7%10.4%10.9%5.2%5.3%
Revenue growth7.0%6.3%3.7%17.4%1.9%-0.3%
Earnings growth20.0%-18.8%67.0%-689.1%33.8%-304.2%
Current ratio2.50x1.84x2.20x1.92x1.76x1.91x
Debt to equity0.44x0.58x0.63x0.65x0.78x0.79x
Equity ratio56.0%51.8%49.6%47.4%43.8%44.8%
Interest coverage12.86x9.35x10.07x9.81x-6.44x-3.80x
R&D as a share of sales4.3%4.8%4.5%9.5%21.0%19.4%
Buybacks as a share of market value-1.3%-0.8%-8.3%7.4%0.0%0.3%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue5.7%7.1%4.4%
Operating income23.8%——
Net income17.6%—38.6%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin41.3%39.5%38.7%38.2%
Operating margin11.2%10.2%5.7%2.3%
Net margin10.3%10.3%7.0%4.6%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings13.816.713.620.4-113.1-162.1208.0328.188.2217.9
Price to sales1.51.61.71.61.81.91.21.31.51.7

Dividends and splits

Per share, in the currency the company pays

Paid for 24 years. Last went ex-dividend on 24 Jul 2026.

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Paid in the year0.9430.8480.8480.7850.1570.1570.1570.078
  • 1050-for-1000 split · 2 Sept 2025
  • 27-for-25 split · 4 Sept 2024
  • 1.04-for-1 split · 1 Sept 2016
  • 27-for-25 split · 28 Aug 2014
  • 1.035-for-1 split · 27 Jul 2010
  • 27-for-25 split · 3 Aug 2006

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.